Regular Article131I-MIBG radionuclide therapy is safe and cost-effective in the control of symptoms of the carcinoid syndrome
References (19)
- et al.
Hepatic resection for metastatic neuroendocrine carcinomas
Am J Surg
(1995) - et al.
Yttrium-9O-labelled somatostatin analogue for cancer treatment
Lancet
(1998) - et al.
Radionuclide therapy
Lancet
(1999) - et al.
Carcinoid tumours
N Engl J Med
(1999) - et al.
Apudomas metastatic to the liver: treatment by hepatic artery embolization
Radiology
(1983) Gastrointestinal carcinoids – aspects of diagnosis and classification
APMIS
(1996)- et al.
The effect of somatostatin analogue on the release of hormones from human midgut carcinoid tumour cells
Br J Cancer
(1991) - et al.
Palliative effect of metaiodobcnzylguanidine in metastatic carcinoid tumors
J Clin Oncol
(1996) - et al.
Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria
Investigational New Drugs
(1992)
There are more references available in the full text version of this article.
Cited by (0)
- f1
Correspondence to: Mr G. Poston, Consultant Surgeon, Royal Liverpool University Hospital, Prescot Street, Liverpool L7 8XP, UK. Tel: +44 151 706 3484; Fax: +44 151 706 5827
Copyright © 2001 Harcourt Publishers Ltd. All rights reserved.